ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC)

Lobbying for ARDELYX, INC. · Biopharmaceutical company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $90,000.00 income · posted Jul 20, 2025

Bills named in this filing 2

Lobbying activity 1

Medicare/Medicaid

Issues related to reimbursement under Medicare Part D; H.R. 5074/S.4510, the Kidney PATIENT Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.